Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus ...
The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...
In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...
A vaccine for pregnant women, which can protect their infants from the RSV illness after birth, has been approved by the U.S. Food and Drug Administration. The FDA recently approved Abrysvo, a ...
New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...
The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...
U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...
Health Minister Stephen Donnelly will update the Cabinet this morning about plans to deal with viruses circulating this ...
GSK plc (GSK, GSK.L) said Japan's Ministry of Health, Labour and Welfare has approved Arexvy for the prevention of respiratory ...
Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.
(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60. Arexvy is a vaccine used for the prevention of respiratory syncytial ...
Visiongain has published a new report entitled Anti-infective Vaccines Market Report 2023-2033: Forecasts by Vaccine Type (Seasonal Influenza Vaccine, Shingles, Tdap Containing /DTaP Primary Vaccine, ...
